RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Rx and /or OTC dermatology products
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Seeking very late stage and market ready prescription products or medical devices for the US market.
Our clients seek prescription products, medical devices and nutraceuticals focused in the following therapeutic areas: urology, pediatrics, ENT, dermatology, OBGYN, family medicine, obesity and rheumatoid arthritis. More
Seeking novel delivery technologies for oral solid (tablets and capsules) medications
Seeking to identify finished oral drug delivery technologies to in-license or acquire from any geographical region. More
Orally delivered modified release drug delivery systems to overcome first-pass metabolism.
A global OTC drug products group with offices in the UK is seeking orally delivered modified release drug delivery systems that extend the efficacy of active pharmaceutical ingredients (APIs), which are susceptible to a large first-pass metabolism. More
Hospital Prescription Specialty Products: seeking late stage, pre-registration and approved products.
Our client is seeking to in-license hospital based prescription specialty products with a focus in the therapeutic areas of: gastroenterology, urology, oncology and acute care. Injectable agents are prioritized and preferred. More
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology More
Easy-to-use diagnostic kits to diagnose consumer health related conditions
A global health care group is currently seeking technologies that are able to diagnose health related conditions in consumers. More
Oral dissolving thin film technology with high API loading capabilities
A global OTC healthcare company is currently seeking orally dissolving thin film technologies with capabilities to load high amounts of active pharmaceutical ingredients (APIs) greater than 100mg. More
Long lasting adhesion to mucosa of the upper and lower respiratory tracts
A global OTC Pharma products group is seeking technologies, approaches and materials that are able to prolong adhesion to a mucosal surface of the oral, pharyngeal, throat, nasal and upper & lower respiratory tracts. More
Displaying 1..10 of 10 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
King III and IT Outsourcing in South Africa
Apr 2011 - 22 pages - $1,895
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011 - Regional Volume III: Americas
Feb 2011 - 412 pages - $395
The Impact of King III (Chapter 5) on IT in South Africa
Mar 2011 - 26 pages - $1,895
King III in South Africa: A Practical Implementation Guide
Aug 2011 - 21 pages - $1,895
III. Medizinische Klinik – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 27 pages - $500
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Disease (VOD)
Jul 2011 - 5 pages - $500
BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 42 pages - $500
Titan Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 51 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us